Language selection

Search

Details for: RAPAFLO

Company: ALLERGAN INC

DIN DIN name Active Ingredient(s) Strength Dosage Form Route of Administration
02361671RAPAFLOSILODOSIN8 MGCAPSULEORAL
Search Reported Side Effects Report a Side Effect

Summary Reports

Summary Basis of Decision

Consumer Information

This information was provided by the drug’s manufacturer when this drug product was approved for sale in Canada. It is designed for consumers and care givers. It is a summary of information about the drug and will not tell you everything about the drug. Contact your doctor or pharmacist if you have any questions about the drug.

What the medication is used for

Your doctor has prescribed RAPAFLO because you have a medical condition called benign prostatic hyperplasia (BPH). This only occurs in men.

What it does

RAPAFLO relaxes muscles in the prostate, bladder neck and base. This results in improved urine flow, and reduced BPH symptoms.

When it should not be used

Do not use RAPAFLO if you:

  • are allergic to silodosin or to any ingredient in RAPAFLO (see What the nonmedicinal ingredients are);
  • take other alpha1-blockers for high blood pressure;
  • take antifungal or HIV drugs such as ketoconazole, itraconazole (Sporanox®), ritonavir (Kaletra®, Norvir®);
  • have severe liver problem; or
  • have severe kidney problem.
What the medicinal ingredient is

Silodosin

What the non-medicinal ingredients are

D-mannitol, magnesium stearate, pregelatinized starch, and sodium lauryl sulfate. The size #1 and #3 hard gelatin capsules contain gelatin and titanium dioxide. The #1 capsules are printed with edible ink containing FD&C Blue No. 1 Aluminum Lake and yellow iron oxide. The #3 capsules are printed with edible ink containing yellow iron oxide.

What dosage form it comes in

Hard gelatin capsules.
8 mg capsules contain 8 mg of silodosin.
4 mg capsules contain 4 mg of silodosin.

Warnings and precautions

RAPAFLO may lower blood pressure (postural hypotension), and may make you feel dizzy, especially when getting up from a lying or sitting position particularly if you are taking medications to lower blood pressure or have low blood pressure. In such cases, lie down until the symptoms have completely disappeared. Do not drive or operate machinery until you know how RAPAFLO affects you.

RAPAFLO is not indicated nor recommended for use in women and children.

Prostate cancer and BPH cause many of the same symptoms. Prior to starting RAPAFLO, your doctor will examine you to rule out the presence of prostate cancer.

Tell your doctor or pharmacist, before using the medication, if:

  • you suffer liver or kidneys problems;
  • you have ever had a reaction to the ingredients of this medication; or
  • you have had low blood pressure or signs of low blood pressure [fainting, dizziness] after taking another medicine.

If you will have eye surgery, you must inform your eye surgeon that you are currently using RAPAFLO. Intraoperative Floppy Iris Syndrome (IFIS) has been reported during cataract surgery in some patients who take or have taken alpha1-blockers.

Interactions with this medication

RAPAFLO is broken down by specific enzymes in the liver. It is not known how combined use of drugs, or herbal products that are also broken down by the same enzymes, or grapefruit juice may influence the effectiveness or unwanted side effects of these drugs or herbal medicines.

Before using any prescription, over-the-counter medicines or herbal products, check with your doctor or your pharmacist.

Drugs that interact with RAPAFLO include:

  • Alpha1-blockers for high blood pressure or prostate problems
  • Certain anti-infection drugs such as ketoconazole, clarithromycin, itraconazole (Sporanox®) and ritonavir (Kaletra®, Norvir®)
Proper use of this medication

Usual dose

Follow your doctor’s instructions very carefully about how to take RAPAFLO.

The recommended dosage is one capsule (8 mg) daily to be taken right after a meal, at the same time each day.

For those with moderate renal impairment, the recommended dosage is one capsule (4 mg) daily to be taken right after meal, at the same time each day.

If you stop taking RAPAFLO for several days, you must check with your doctor before starting it again.

Overdose

Overdose of silodosin may lead to low blood pressure and change in heart rate.

In case of drug overdose, contact a health care practitioner, hospital emergency department or regional Poison Control Centre immediately, even if there are no symptoms.
Side effects and what to do about them

Like all prescription drugs, RAPAFLO may cause side effects.

The most common side effect seen with RAPAFLO is an orgasm with reduced or no semen. This side effect is reversible with discontinuation of the product. Other common side effects include dizziness, diarrhea, lightheadedness upon standing or sitting up abruptly, headache, swelling of the throat and nasal passages, and stuffy nose. Cases of itching, hives, shortness of breath, eosinophilic pneumonia (cough, fever, difficulty breathing), dry cough, swelling under the skin, peeling of skin, redness of skin, and swelling of the face have also been reported. If these side effects persist or become bothersome, please check with your physician or pharmacist.

As with other alpha-blockers, RAPAFLO can cause a drop in blood pressure upon changing from a sitting to a standing position, especially when you start treatment. This may lead to fainting, dizziness, or lightheadedness, upon standing or sitting up abruptly. Be careful when driving, operating machinery, or when doing any dangerous activities until you know how RAPAFLO affects you. This is important if you already have a problem with low blood pressure or take medicines to treat high blood pressure. If you begin to feel dizzy or lightheaded, lie down with your legs and feet up. If your symptoms do not improve call your doctor.

If you are undergoing cataract surgery or surgery because of cloudiness in your lens you should inform your ophthalmologist that you are taking RAPAFLO.

Serious side effects, how often they happen and what to do about them
Symptom / effect Talk with your doctor or pharmacist Only if severe Talk with your doctor or pharmacist In all cases Stop taking drug and call your doctor or pharmacist
Common
Dizziness    
Headache    
Uncommon
Fainting    
Lightheadedness upon standing or sitting up abruptly    
Liver disease or liver problems    
Allergic reactions (swollen tongue, swollen throat)    
Skin rash    
Red or purple discoloration of the skin caused by bleeding underneath the skin (known as purpura)    
Fast heart rate (tachycardia)    
Rare
Feeling of rapid beating of the heart that may be more forceful (palpitation)    
This is not a complete list of side effects. For any unexpected effects while taking RAPAFLO, contact your doctor or pharmacist.
How to store

RAPAFLO capsules should be stored at controlled room temperature (15°C to 30°C). Protect from light and moisture.

Keep RAPAFLO out of reach of children.

Reporting side effects

You can report any suspected adverse reactions associated with the use of health products to the Canada Vigilance Program by one of the following 3 ways:


  • Report online at www.healthcanada.gc.ca/medeffect
  • Call toll-free at 1-866-234-2345
  • Complete a Canada Vigilance Reporting Form and:
    • Fax toll-free to 1-866-678-6789, or
    • Mail to: Canada Vigilance Program
      Health Canada
      Postal Locator 0701E
      Ottawa, Ontario
      K1A 0K9

    Postage paid labels, Canada Vigilance Reporting Form and the adverse reaction reporting guidelines are available on the MedEffectTM Canada Web site at www.healthcanada.gc.ca/medeffect.

NOTE: Should you require information related to the management of side effects, contact your health professional. The Canada Vigilance Program does not provide medical advice.

More information

This document plus the full product monograph, prepared for health professionals, can be found at allergan.ca or by contacting Allergan Pharma Co. at 1-800-668-6424.

This leaflet was prepared by:
Allergan Pharma Co.
Markham, Ontario L6G 0B5

Under Licence From:
Kissei Pharmaceutical Co., Ltd.
Nagano
JAPAN

RAPAFLO® and its design are registered trademarks of Allergan Sales, LLC, used under license by Allergan Inc.
Date of Preparation: March 12, 2018

Date modified: